What is ATRA stock price today?

Visit our real-time dashboard for the current ATRA stock price and live market data.

Is ATRA stock going up or down today?

ATRA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ATRA stock now?

The decision to buy ATRA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ATRA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ATRA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ATRA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ATRA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ATRA's P/E ratio?

P/E ratio data for ATRA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ATRA's market cap?

ATRA (Atara Biotherapeutics Inc) has a market capitalization of $0.09 billion, making it a small-cap stock.

What is ATRA's price to book ratio?

ATRA trades at a price-to-book (P/B) ratio of 16.14, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ATRA pay dividends?

ATRA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ATRA's dividend yield?

ATRA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ATRA stock a good long-term investment?

ATRA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ATRA's revenue growth rate?

Revenue growth data for ATRA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ATRA are available on our dashboard with complete income statement analysis.

What are the risks of investing in ATRA?

Key risks for ATRA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ATRA compare to its competitors?

Compare ATRA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ATRA's performance and positioning.

What is ATRA's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ATRA with bull, base, and bear case scenarios.

What do analysts say about ATRA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ATRA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ATRA's next earnings report?

ATRA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ATRA - Atara Biotherapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Atara Biotherapeutics Inc

Atara Biotherapeutics Inc (ATRA) common stock

Price Chart

Loading chart...

ATRA Key Statistics

Market Cap

$87.13M

P/B Ratio

16.14

How ATRA Compares to Peers

ATRA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ATRA(This stock)	$87.13M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 8:02 PM EDT

Ready to invest in ATRA?

Commission-free trading available. Affiliate links.

ATRA Lician Score

10% confidence

5.0/10

Neutral

ATRA has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ATRAacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ATRA Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ATRA

Dashboard

Enter a ticker to analyze